Merck Extends Immunotherapy Lead With Lung Cancer Combination Therapy Approval – TheStreet.com
TheStreet.com |
Merck Extends Immunotherapy Lead With Lung Cancer Combination Therapy Approval
TheStreet.com FDA approvals of immunotherapies used alone to treat various cancers have become almost routine, but the agency's latest affirmative nod to Merck marks the first time that an immunotherapy has been combined with another drug to kill cancer cells more … US FDA approves Merck immunotherapy/chemo combo for lung cancer Merck boosted by FDA approval for Keytruda use with chemo |
